Cidara Therapeutics, Inc. — Director's Dealing 2021

Jan 25, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cidara Therapeutics, Inc. (CDTX)
CIK: 0001610618
Period of Report: 2021-01-22

Reporting Person: Canale-Theakston Carin (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-22	Stock Option (right to buy)	$2.51	A	35000	Acquired	2031-01-21	Common Stock (35000)	Direct

Footnotes

F1: 1/3rd of the total number of shares subject to the award shall vest on January
22, 2022 and the remaining 2/3rds of the shares will vest in equal monthly installments over a two year period such that the option is fully vested on January 22, 2024.